Biomia

Health Care · Neurology & CNS Therapeutics

Overview

Biomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders.

Funding and backers

Backers
2
Amino Collective, BlueYard Capital
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PronirasVenture round $6.9M · 2 yr ago · Founded 2016 · 11-50 employees
About Us Proniras Corporation ("Proniras") is a clinical-stage biotechnology company focused on the development of novel small-molecule…
Five DiscoveryConvertible Note $150k · 10 mo ago · Founded 2025
Five Discovery is a regenerative neurology biotech developing non-hallucinogenic neuroplastogens to repair brain circuits in Parkinson’s…
Nanocarry1-10 employees
Biologics Beyond Boundaries. Developing first-in-class therapeutics to treat brain cancers and CNS diseases.
Slate MedicinesSeries A $130M · 8 mo ago · Founded 2024 · 51-200 employees
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
Damona PharmaceuticalsSeed $5.5M · 4 yr ago · 51-200 employees
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
Applied Cognition is a platform therapeutic company developing drugs to enhance brain glymphatic function and treat Alzheimer’s disease.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
31 portfolio companies: Vira Health, Theorema, Validtx and 28 more
66 portfolio companies: Vigil Markets, Radworks, Metapalsclub and 63 more

News

News FinanzNachrichten.de 10 months ago
IRLAB Therapeutics: IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, SE / ACCESS Newswire / January 19, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company
Read more
Report
News Nature Index 1 year ago
Biomia ApS
Research outputs, collaborations and relationships for Biomia ApS
Read more
Report